l General Information |
Product Name | BH3I-1 |
General description | BH3I-1 is a selective inhibitor of Bcl-2 family proteins. |
Synonym | (E)-2-(5-(4-bromobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-3-methylbutanoic acid |
Purity | ≥98%(HPLC) | CAS Number | 300817-68-9 |
Formula | C15H14BrNO3S2 | Molecular Weight | 400.305 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Orange solid |
Solubility(25℃) | DMSO | ≥40mg/mL |
Ethanol | ~10mg/mL |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | BH3I-1is a synthetic cell permeable Bcl-xL antagonist; apoptosis inducer. |
l Packaging & Storage |
Packaging | 10mg; 50mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
